Skip to content
Colorectal Cancer Clinical Trials

Columbus, Ohio

Colorectal cancer clinical trials in Columbus, OH

35 colorectal cancer studies are recruiting participants at sites in Columbus as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Columbus at a glance

  • 35 studies are recruiting at a site in Columbus.
  • By phase: Phase 1 (6), Phase 1/2 (8), Phase 2 (4), Phase 2/3 (2), Phase 3 (4), Phase 4 (1), No phase (6), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (22), university, hospital or other (11), government (2).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Columbus

Basic details from each study's public record (the 30 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05863195 · updated
  2. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06102902 · updated
  3. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05080673 · updated
  4. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Mount Carmel East Hospital · Mount Carmel Health Center West · Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05174169 · updated
  5. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Mount Carmel East Hospital · Mount Carmel Health Center West · Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05334069 · updated
  6. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    The Ohio State University (OSU) Wexner Medical Center
    Registry record
    NCT06400472 · updated
  7. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    The Jame Outpatient Care West Campus
    Registry record
    NCT07397338 · updated
  8. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05673148 · updated
  9. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    Ohio State University
    Registry record
    NCT03526835 · updated
  10. A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Ohio State University-Arthur G James Comprehensive Cancer Center
    Registry record
    NCT07284849 · updated
  11. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Ohio State University
    Registry record
    NCT06710756 · updated
  12. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    The Ohio State University Comprehensive Cancer Center
    Registry record
    NCT04981119 · updated
  13. A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center
    Registry record
    NCT07221357 · updated
  14. Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05630794 · updated
  15. SMP-3124LP in Adults With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sumitomo Pharma America, Inc.
    Study site
    Ohio State University
    Registry record
    NCT06526819 · updated
  16. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Ohio State University
    Registry record
    NCT06026410 · updated
  17. A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Ohio State University Comprehensive Cancer Center
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06424522 · updated
  18. A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ALX Oncology Inc.
    Study site
    ALX Center 10
    Registry record
    NCT07085091 · updated
  19. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05489211 · updated
  20. Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Medtronic - MITG
    Study site
    The Ohio State University Wexner Medical Center
    Registry record
    NCT07351071 · updated
  21. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Marengo Therapeutics, Inc.
    Study site
    The Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05592626 · updated
  22. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  23. A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ono Pharmaceutical Co., Ltd.
    Study site
    The Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06948448 · updated
  24. Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Canadian Cancer Trials Group
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06205485 · updated
  25. Strategies for Optimizing a Mailed FIT Program in Appalachia

    • No phase
    • Ages 45 to 74
    • All sexes
    Sponsor
    Ohio State University Comprehensive Cancer Center
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT07173985 · updated
  26. A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    Takeda
    Study site
    Zangmeister Cancer Center
    Registry record
    NCT06562543 · updated
  27. Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Rapamycin Holdings Inc.
    Study site
    Ohio State University
    Registry record
    NCT06950385 · updated
  28. A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Turning Point Therapeutics, Inc.
    Study site
    The Ohio State University Wexner Medical Center
    Registry record
    NCT03093116 · updated
  29. Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

    • Phase 2
    • Ages 50 and older
    • Female participants
    Sponsor
    Ohio State University Comprehensive Cancer Center
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT07407647 · updated
  30. Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Ohio State University Comprehensive Cancer Center
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06746012 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Columbus, OH on ClinicalTrials.gov.

Ask about studies near Columbus

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Ohio

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call